Advertisement

Topics

Global Biopharma Market Research Report 20112023 [Report Updated: 06112017] Prices from USD $3610

13:54 EST 15 Nov 2017 | BioPortfolio Reports

Summary

The global Biopharma market will reach xxx Million USD in 2017 with CAGR xx% 20182023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

Monoclonal Antibodies

Recombinant Proteins

GranulocyteColony Stimulating Factor GCSF

Interferons

Recombinant Human Insulin

Erythropoietin

Vaccines

Growth Hormones

Purified Proteins

Others

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

Pfizer

F. HoffmannLa Roche AG

Johnson Johnson Services

Sanofi, Amgen

AbbVie

Merck Co.

Biogen Idec

Bayer AG

Eli Lilly and Company

Novartis AG GlaxoSmithKline Plc

BristolMyers Squibb Company

AstraZeneca PLC

Abbott Laboratories

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

Metabolic Disorders

Oncology

Neurological Disorders

Cardiovascular Diseases

Inflammatory and Infectious Diseases

Others

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

AsiaPacific

North America

Europe

South America

Middle East Africa

Original Article: Global Biopharma Market Research Report 20112023 [Report Updated: 06112017] Prices from USD $3610

NEXT ARTICLE

More From BioPortfolio on "Global Biopharma Market Research Report 20112023 [Report Updated: 06112017] Prices from USD $3610"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...